$AME

Stanage Nick L purchased $1.0M of AME

Stanage Nick L purchased 4,000 shares of AMETEK INC/ (AME) at $255.85 ($1.02M total) on 2026-08-11.

Original reporting
SEC EDGAR · Stanage Nick L
Published Aug 12, 2026, 8:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 12, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AME
Neutral
medium confidence
Mentioned
$AME
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMENeutralLow
01

Why it matters

The disclosed fact is the size and price of the director’s purchase, which can slightly influence sentiment but does not change the company’s disclosed outlook.

02

Market read

Traders may note the insider buying as a small positive signal, but it is unlikely to be a standalone catalyst.

03

What to watch

No 10b5-1 plan is cited, but the article also provides no context on prior holdings, motivation, or whether other insiders acted.

Relevance 7/10Novelty 3/10Timing: filed 2026-08-12 after-hours; trade signal is based on 2026-08-11 purchase

Background

This is an SEC Form 4 insider transaction disclosure for AMETEK, reported from an open-market purchase by a director.

Company-level read

Ticker impact

$AMENeutralMedium confidence
Context

Director Stanage Nick L bought 4,000 shares of AMETEK at $255.85 on 2026-08-11, totaling $1.02M, per Form 4.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades.

Evidence & confidence

The filing is primary-source and time-stamped, but it does not include new company fundamentals, guidance, or operational/regulatory developments.

Market effects

No clear sector read-through from a single AMETEK director purchase.

None indicated.

None indicated.

Counterpoint

Insider purchases can be routine, tax- or liquidity-driven, and may not reflect a new view on near-term fundamentals.

Key entities

  • AME

    AMETEK Inc., the issuer of the Form 4 insider transaction.

  • Stanage Nick L

    Director who purchased 4,000 shares on 2026-08-11 at $255.85.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMEHighAI 9/10

AMETEK Posts Record Q3 Sales and Adjusted EPS, Raises 2026 Guidance

AMETEK reported Q3 2026 sales of $2.22B, up 17% YoY, and adjusted EPS of $2.21. GAAP EPS was $1.85, with net income at $426.3M. The company raised its full-year adjusted EPS outlook to $8.53–$8.57. Growth was driven by organic sales, acquisitions, and strong demand across its businesses. AMETEK also completed the acquisition of Indicor Instrumentation.

$AMEHighAI 9/10

AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AMETEK Announces Record Third Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Nov 3, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the third quarter ended September 30, 2026. AMETEK’s third quarter 2026 sales were a record

$AMEMedAI 8/10

AMETEK Boosts FY26 Outlook - Update

AMETEK (AME) reported Q3 results and raised its FY26 outlook. Q4 adjusted earnings are expected to be $2.26-$2.30 per share with net sales growth in the low 20% range. FY26 adjusted earnings are now projected to be $8.53-$8.57 per share with mid-teen percentage net sales growth, up from previous guidance of $8.20-$8.30 per share. AME stock is up 0.86% in pre-market trading.

$AMEMedAI 9/10

AMETEK’s (NYSE:AME) Q3 2026 sales beat estimates

AMETEK reported Q3 2026 revenue of $2.22 billion, exceeding estimates by 2.9% and growing 17.3% year-on-year. Adjusted EPS was $2.21, beating estimates by 4.8%. Management raised full-year adjusted EPS guidance to $8.55 at the midpoint, a 3.6% increase. Operating margin remained steady at 26.3%, while free cash flow margin improved to 23.8% from 22.2% year-on-year.